Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial (vol 22, pg 494, 2023)

被引：0
作者：
Granit, V
Benatar, M.
Kurtoglu, M.
机构：
来源：
LANCET NEUROLOGY | 2023年 / 22卷 / 09期
关键词：
D O I：
10.1016/S1474-4422(23)00282-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E10 / E10
页数：1
相关论文
共 1 条
  • [1] Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
    Stimming, Erin Furr
    Claassen, Daniel
    Kayson, Elise
    Goldstein, Jody
    Mehanna, Raja
    Zhang, Hui
    Liang, Grace S.
    Haubenberger, Dietrich
    [J]. LANCET NEUROLOGY, 2023, 22 (06) : 494 - 504
1